{"gao_id": "GAO-17-363SP", "published": "2017-03-31T12:00:00Z", "released": "2017-03-31T08:00:00Z", "summary": "This is a companion to our report, Drug Compounding: FDA Has Taken Steps to Implement Compounding Law, but Some States and Stakeholders Reported Challenges , GAO-17-64 . States oversee drug compounding, which creates drugs tailored for individual patients; the Food and Drug Administration also oversees this practice at the federal level. We surveyed the state pharmacy regulatory bodies in the 50 states, the District of...", "title": "Drug Compounding: Survey of State Pharmacy Regulatory Bodies (GAO-17-363SP, March 2017), an E-supplement to GAO-17-64", "topics": ["Prescription drugs", "Physicians", "Pharmacist", "Health Care", "Outsourcing", "Food and drug legislation", "Drugs", "Pharmacy", "Food and drug law", "Compliance oversight"], "type": "reports-testimonies", "url": "https://www.gao.gov/products/gao-17-363sp", "versions": []}